 |
0 Diseases |  |
0 Trials |
|
0 Trials |  |
147 News |  |
| «123 |
- Clopixol (zuclopenthixol) / Lundbeck
New trial: Antipsychotics and Risk of Hyperglycemic Emergencies (clinicaltrials.gov) - Oct 22, 2015
P=N/A, N=725489, Completed, Sponsor: Canadian Network for Observational Drug Effect Studies, CNODES
- | New P4 trial: APIC: Antipsychotic Induced Structural and Functional Brain Changes (clinicaltrials.gov) - May 7, 2015
P4, N=666, Not yet recruiting, Sponsor: RWTH Aachen University
- |||||||||| New P3 trial, Adverse events: Pharmacovigilance in Gerontopsychiatric Patients (clinicaltrials.gov) - Mar 2, 2015
P3, N=2000, Recruiting, Sponsor: Hannover Medical School
- Clopixol (zuclopenthixol) / Lundbeck, Serlect (sertindole) / Lundbeck, Abbott
Trial primary completion date: Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective Psychosis (clinicaltrials.gov) - Dec 6, 2014
P3, N=104, Recruiting, Sponsor: Fundaci
Trial primary completion date: Nov 2013 --> Nov 2015
- Lazanda (fentanyl) / Assertio, Kyowa Kirin, Epistatus (midazolam oromucosal solution) / Veriton Pharma
New P4 trial: Nasal Fentanyl and Buccal Midazolam for Dying Patients (clinicaltrials.gov) - Dec 9, 2013
P4, N=20, Not yet recruiting, Sponsor: Gloucestershire Hospitals NHS Foundation Trust
- |||| ADX71149 / J&J, Addex
Trial completion, Monotherapy: Investigation of the Safety, Tolerability and Potential Therapeutic Effects of JNJ-40411813 in Patients With Schizophrenia (clinicaltrials.gov) - Feb 28, 2013
P2, N=100, Completed, Sponsor: Janssen Research & Development, LLC
Trial primary completion date: Nov 2013 --> Nov 2015 Recruiting --> Completed
- || Clopixol (zuclopenthixol) / Lundbeck, Serlect (sertindole) / Lundbeck, Abbott
New P3 trial: Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective Psychosis (clinicaltrials.gov) - Jan 8, 2013
P3, N=104, Recruiting, Sponsor: Fundaci
- olanzapine / Generic mfg., haloperidol / Generic mfg.
Trial termination: Haloperidol vs Olanzapine for the Management of ICU Delirium (clinicaltrials.gov) - Aug 1, 2012
P=N/A, N=200, Terminated, Sponsor: Richard Hall
Recruiting --> Completed Recruiting --> Terminated